Erasca: Funding, Investors & Team (Oct 2026)
Our mission at Erasca is embedded in our name: To erase cancer. Energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology’s hardest problems. We have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals. In addition to our initial programs for undisclosed cancer targets, we seek to expand our pipeline through partnerships with academic scientists and biopharmaceutical companies who have revealed potential new mechanisms for precision oncology. Importantly, Erasca isn’t tied to one form of drug or any singular approach to treating cancer. By keeping an open mind about what is possible, we believe we will achieve the greatest results for patients everywhere.
Erasca has raised $395M across 3 funding rounds on record, the most recent an undisclosed round of $259M announced in Jan 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Erasca Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Erasca Funding Rounds
Erasca raised $36.0M in an undisclosed round announced in Aug 2020.
2.3 years later, an undisclosed round of $100M was announced in Dec 2022.
3.1 years later, an undisclosed round of $259M was announced in Jan 2026.
Erasca Founders and Leadership Team
No contact details are on record for this team yet.
Erasca Funding Compared to Other Biotechnology Startups
Erasca's latest round of $259M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Erasca in Biotechnology and San Diego
Companies Similar to Erasca
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Erasca Funding FAQs
What does Erasca do?
Our mission at Erasca is embedded in our name: To erase cancer. Energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology’s hardest problems. We have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals. In addition to our initial programs for undisclosed cancer targets, we seek to expand our pipeline through partnerships with academic scientists and biopharmaceutical companies who have revealed potential new mechanisms for precision oncology. Importantly, Erasca isn’t tied to one form of drug or any singular approach to treating cancer. By keeping an open mind about what is possible, we believe we will achieve the greatest results for patients everywhere.
How much funding has Erasca raised?
Erasca has raised $395M across 3 rounds on record. The most recent is an undisclosed round of $259M announced in Jan 2026.
When did Erasca last raise funding?
Erasca's most recent funding round on record is an undisclosed round of $259M, announced in Jan 2026.
Who is the CEO of Erasca?
Jonathan L is listed as CEO at Erasca.
Where is Erasca headquartered?
Erasca is based in San Diego, California, United States.
How many employees does Erasca have?
Erasca is in the 101-250 employee band.
How does Erasca's funding compare to other Biotechnology startups?
Erasca's latest round of $259M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Erasca Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Erasca is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.